AcelRx制药 ACRX 深 沪
已收盘 01-09 16:00:00 美东时间
0.86
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.86
- 总市值 1405.25万
- 52周最高 2.75
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.425
- 委 比 0.00%
- 总股本 1634.01万
- 历史最高 272.80
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.425
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多AcelRx Pharmaceuticals GAAP EPS of -$0.07 beats by $0.09
AcelRx Pharmaceuticals press release (NASDAQ:TLPH): Q4 GAAP EPS of -$0.07 beats by $0.09. Shares +0.06%. The cash and cash equivalents balance was $8.9 million as of December 31, 2024. 2025 Expense Gu...
2025-04-01 04:07
AcelRx Pharmaceuticals Q1 2024 Earnings Preview
AcelRx Pharmaceuticals (NASDAQ:TLPH) is scheduled to announce Q1 earnings results on Tuesday, May 14th, after market close. The consensus EPS Estimate is -$0.21. Over the last 3 months, EPS estimates ...
2024-05-14 05:20
Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket
Shares of Green Giant Inc. (NASDAQ: GGE) fell sharply in pre-market trading after announcing a proposed public offering. Green Giant shares dipped 37.1% to $0.1599 in pre-market trading. Here are some other stocks moving in pre-market trading.
2023-12-11 20:59
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Onconova Therapeutics (NASDAQ:ONTX) shares moved upwards by 42.5% to $...
2023-12-09 05:30
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers AnaptysBio (NASDAQ:ANAB) shares moved upwards by 17.9% to $22.7 during...
2023-10-09 21:06
Why Galecto Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
Gainers
2023-09-27 20:15
AcelRx Pharmaceuticals to Participate in the H.C. Wainwright Annual Investment Conference
SAN MATEO, Calif., Sept. 6, 2023 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...
2023-09-06 20:30
Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2023
Upgrades For Docebo Inc (NASDAQ:DCBO), Morgan Stanley upgraded the previous rat...
2023-08-18 23:00
AcelRx Pharmaceuticals Analyst Ratings
What is the target price for AcelRx Pharmaceuticals (ACRX)?The latest price tar...
2023-08-18 18:20
AcelRx Pharmaceuticals Q2 EPS $(0.40) Beats $(0.53) Estimate, Sales $253.00K Beat $70.00K Estimate
AcelRx Pharmaceuticals (NASDAQ:ACRX) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.53) by 24.53 percent. This is a 66.67 percent increase over losses of $(1.20) per share
2023-08-11 04:39
